nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—Aminohippurate—Balsalazide—Crohn's disease	0.397	1	CrCrCtD
Procainamide—SLC22A4—Crohn's disease	0.292	0.571	CbGaD
Procainamide—SLC22A5—Crohn's disease	0.22	0.429	CbGaD
Procainamide—Drug fever—Mercaptopurine—Crohn's disease	0.00317	0.0892	CcSEcCtD
Procainamide—Lupus-like syndrome—Mesalazine—Crohn's disease	0.00244	0.0686	CcSEcCtD
Procainamide—Drug fever—Mesalazine—Crohn's disease	0.00172	0.0484	CcSEcCtD
Procainamide—Lupus erythematosus—Mesalazine—Crohn's disease	0.00154	0.0434	CcSEcCtD
Procainamide—Pericarditis—Mesalazine—Crohn's disease	0.00133	0.0374	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.00104	0.0292	CcSEcCtD
Procainamide—Sunitinib—LRRK2—Crohn's disease	0.000835	0.216	CrCbGaD
Procainamide—Pleural effusion—Mesalazine—Crohn's disease	0.00075	0.0211	CcSEcCtD
Procainamide—Vasculitis—Azathioprine—Crohn's disease	0.000646	0.0182	CcSEcCtD
Procainamide—Sunitinib—TYK2—Crohn's disease	0.000633	0.164	CrCbGaD
Procainamide—Sunitinib—JAK2—Crohn's disease	0.000633	0.164	CrCbGaD
Procainamide—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.000607	0.0171	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—Crohn's disease	0.000528	0.45	CbGdCrCtD
Procainamide—Aminohippurate—SLC22A4—Crohn's disease	0.000511	0.132	CrCbGaD
Procainamide—Hepatic failure—Azathioprine—Crohn's disease	0.000509	0.0143	CcSEcCtD
Procainamide—Hepatic failure—Mesalazine—Crohn's disease	0.000464	0.0131	CcSEcCtD
Procainamide—SCN11A—digestive system—Crohn's disease	0.000455	0.0757	CbGeAlD
Procainamide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00044	0.0124	CcSEcCtD
Procainamide—Renal impairment—Mesalazine—Crohn's disease	0.000438	0.0123	CcSEcCtD
Procainamide—Hepatomegaly—Prednisone—Crohn's disease	0.000429	0.0121	CcSEcCtD
Procainamide—Arthritis—Mesalazine—Crohn's disease	0.000429	0.0121	CcSEcCtD
Procainamide—Lethargy—Mesalazine—Crohn's disease	0.000425	0.012	CcSEcCtD
Procainamide—Arthralgia—Mercaptopurine—Crohn's disease	0.000394	0.0111	CcSEcCtD
Procainamide—DNMT1—epithelium—Crohn's disease	0.000391	0.065	CbGeAlD
Procainamide—Probenecid—SLC22A5—Crohn's disease	0.000389	0.101	CrCbGaD
Procainamide—Aminohippurate—SLC22A5—Crohn's disease	0.000384	0.0993	CrCbGaD
Procainamide—Abdominal pain upper—Mesalazine—Crohn's disease	0.000381	0.0107	CcSEcCtD
Procainamide—Abdominal discomfort—Azathioprine—Crohn's disease	0.000379	0.0107	CcSEcCtD
Procainamide—SLC22A3—mouth—Crohn's disease	0.000379	0.063	CbGeAlD
Procainamide—Lidocaine—SLC22A5—Crohn's disease	0.000374	0.0968	CrCbGaD
Procainamide—DNMT1—skin of body—Crohn's disease	0.000372	0.0618	CbGeAlD
Procainamide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00037	0.0104	CcSEcCtD
Procainamide—Anorexia—Mercaptopurine—Crohn's disease	0.00036	0.0101	CcSEcCtD
Procainamide—Eosinophilia—Mesalazine—Crohn's disease	0.000357	0.01	CcSEcCtD
Procainamide—Abdominal discomfort—Mesalazine—Crohn's disease	0.000345	0.00972	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000344	0.00968	CcSEcCtD
Procainamide—DNMT1—mammalian vulva—Crohn's disease	0.000339	0.0564	CbGeAlD
Procainamide—Neutropenia—Mesalazine—Crohn's disease	0.000337	0.00948	CcSEcCtD
Procainamide—Agranulocytosis—Azathioprine—Crohn's disease	0.000329	0.00926	CcSEcCtD
Procainamide—Decreased appetite—Mercaptopurine—Crohn's disease	0.000328	0.00924	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Prednisone—Crohn's disease	0.000323	0.275	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—Crohn's disease	0.000323	0.275	CbGdCrCtD
Procainamide—Depression—Mesalazine—Crohn's disease	0.00032	0.00901	CcSEcCtD
Procainamide—Renal failure—Mesalazine—Crohn's disease	0.000316	0.00889	CcSEcCtD
Procainamide—Vasculitis—Prednisone—Crohn's disease	0.000311	0.00876	CcSEcCtD
Procainamide—DNMT1—lymphoid tissue—Crohn's disease	0.000301	0.0501	CbGeAlD
Procainamide—Agranulocytosis—Mesalazine—Crohn's disease	0.0003	0.00844	CcSEcCtD
Procainamide—Body temperature increased—Mercaptopurine—Crohn's disease	0.000298	0.0084	CcSEcCtD
Procainamide—DNMT1—digestive system—Crohn's disease	0.000297	0.0495	CbGeAlD
Procainamide—Chills—Azathioprine—Crohn's disease	0.000284	0.00799	CcSEcCtD
Procainamide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000278	0.00783	CcSEcCtD
Procainamide—Cardiac disorder—Mesalazine—Crohn's disease	0.000268	0.00753	CcSEcCtD
Procainamide—Chills—Mesalazine—Crohn's disease	0.000259	0.00728	CcSEcCtD
Procainamide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000258	0.00727	CcSEcCtD
Procainamide—Ill-defined disorder—Azathioprine—Crohn's disease	0.000256	0.0072	CcSEcCtD
Procainamide—Malaise—Azathioprine—Crohn's disease	0.000249	0.00699	CcSEcCtD
Procainamide—SLC22A2—digestive system—Crohn's disease	0.000248	0.0413	CbGeAlD
Procainamide—Dysgeusia—Mesalazine—Crohn's disease	0.000246	0.00692	CcSEcCtD
Procainamide—Vomiting—Mercaptopurine—Crohn's disease	0.00024	0.00676	CcSEcCtD
Procainamide—Arthralgia—Azathioprine—Crohn's disease	0.000235	0.0066	CcSEcCtD
Procainamide—Myalgia—Azathioprine—Crohn's disease	0.000235	0.0066	CcSEcCtD
Procainamide—SCN10A—lymphoid tissue—Crohn's disease	0.000234	0.0389	CbGeAlD
Procainamide—Ill-defined disorder—Mesalazine—Crohn's disease	0.000233	0.00656	CcSEcCtD
Procainamide—Discomfort—Azathioprine—Crohn's disease	0.000232	0.00652	CcSEcCtD
Procainamide—Angioedema—Mesalazine—Crohn's disease	0.000229	0.00646	CcSEcCtD
Procainamide—Malaise—Mesalazine—Crohn's disease	0.000226	0.00637	CcSEcCtD
Procainamide—Cardiac failure—Prednisone—Crohn's disease	0.000226	0.00636	CcSEcCtD
Procainamide—Lethargy—Prednisone—Crohn's disease	0.000225	0.00633	CcSEcCtD
Procainamide—Nausea—Mercaptopurine—Crohn's disease	0.000224	0.00631	CcSEcCtD
Procainamide—SCN7A—lymph node—Crohn's disease	0.000221	0.0368	CbGeAlD
Procainamide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00022	0.0062	CcSEcCtD
Procainamide—Psychotic disorder—Prednisone—Crohn's disease	0.000215	0.00606	CcSEcCtD
Procainamide—Arthralgia—Mesalazine—Crohn's disease	0.000214	0.00602	CcSEcCtD
Procainamide—Myalgia—Mesalazine—Crohn's disease	0.000214	0.00602	CcSEcCtD
Procainamide—SLC22A3—smooth muscle tissue—Crohn's disease	0.000212	0.0353	CbGeAlD
Procainamide—Discomfort—Mesalazine—Crohn's disease	0.000211	0.00594	CcSEcCtD
Procainamide—Hypotension—Azathioprine—Crohn's disease	0.00021	0.00592	CcSEcCtD
Procainamide—SCN5A—digestive system—Crohn's disease	0.00021	0.0349	CbGeAlD
Procainamide—Cardiac arrest—Prednisone—Crohn's disease	0.00021	0.0059	CcSEcCtD
Procainamide—Confusional state—Mesalazine—Crohn's disease	0.000207	0.00581	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000205	0.00577	CcSEcCtD
Procainamide—Shock—Mesalazine—Crohn's disease	0.000202	0.00567	CcSEcCtD
Procainamide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000201	0.00565	CcSEcCtD
Procainamide—Anorexia—Mesalazine—Crohn's disease	0.000195	0.0055	CcSEcCtD
Procainamide—Hypotension—Mesalazine—Crohn's disease	0.000191	0.00539	CcSEcCtD
Procainamide—SLC22A3—mammalian vulva—Crohn's disease	0.000191	0.0318	CbGeAlD
Procainamide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000187	0.00525	CcSEcCtD
Procainamide—Feeling abnormal—Azathioprine—Crohn's disease	0.000185	0.00522	CcSEcCtD
Procainamide—SLC22A4—digestive system—Crohn's disease	0.000184	0.0306	CbGeAlD
Procainamide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000184	0.00518	CcSEcCtD
Procainamide—Neutropenia—Prednisone—Crohn's disease	0.000178	0.00502	CcSEcCtD
Procainamide—Decreased appetite—Mesalazine—Crohn's disease	0.000178	0.00501	CcSEcCtD
Procainamide—Body temperature increased—Azathioprine—Crohn's disease	0.000178	0.005	CcSEcCtD
Procainamide—Abdominal pain—Azathioprine—Crohn's disease	0.000178	0.005	CcSEcCtD
Procainamide—SCN9A—lymph node—Crohn's disease	0.000173	0.0288	CbGeAlD
Procainamide—DNMT1—lymph node—Crohn's disease	0.00017	0.0282	CbGeAlD
Procainamide—Depression—Prednisone—Crohn's disease	0.000169	0.00477	CcSEcCtD
Procainamide—Feeling abnormal—Mesalazine—Crohn's disease	0.000169	0.00475	CcSEcCtD
Procainamide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000168	0.00472	CcSEcCtD
Procainamide—Hypersensitivity—Azathioprine—Crohn's disease	0.000166	0.00466	CcSEcCtD
Procainamide—Urticaria—Mesalazine—Crohn's disease	0.000163	0.00458	CcSEcCtD
Procainamide—Body temperature increased—Mesalazine—Crohn's disease	0.000162	0.00456	CcSEcCtD
Procainamide—Abdominal pain—Mesalazine—Crohn's disease	0.000162	0.00456	CcSEcCtD
Procainamide—Bradycardia—Prednisone—Crohn's disease	0.000155	0.00437	CcSEcCtD
Procainamide—Diarrhoea—Azathioprine—Crohn's disease	0.000154	0.00433	CcSEcCtD
Procainamide—SLC22A5—skin of body—Crohn's disease	0.000152	0.0253	CbGeAlD
Procainamide—Hallucination—Prednisone—Crohn's disease	0.000152	0.00427	CcSEcCtD
Procainamide—Hypersensitivity—Mesalazine—Crohn's disease	0.000151	0.00425	CcSEcCtD
Procainamide—BCHE—smooth muscle tissue—Crohn's disease	0.00015	0.025	CbGeAlD
Procainamide—Dizziness—Azathioprine—Crohn's disease	0.000149	0.00419	CcSEcCtD
Procainamide—BCHE—skin of body—Crohn's disease	0.000148	0.0247	CbGeAlD
Procainamide—Asthenia—Mesalazine—Crohn's disease	0.000147	0.00414	CcSEcCtD
Procainamide—Pruritus—Mesalazine—Crohn's disease	0.000145	0.00408	CcSEcCtD
Procainamide—Vomiting—Azathioprine—Crohn's disease	0.000143	0.00402	CcSEcCtD
Procainamide—Flushing—Prednisone—Crohn's disease	0.000142	0.00399	CcSEcCtD
Procainamide—Diarrhoea—Mesalazine—Crohn's disease	0.00014	0.00395	CcSEcCtD
Procainamide—ACHE—lymph node—Crohn's disease	0.000138	0.0229	CbGeAlD
Procainamide—Dizziness—Mesalazine—Crohn's disease	0.000135	0.00381	CcSEcCtD
Procainamide—BCHE—mammalian vulva—Crohn's disease	0.000135	0.0225	CbGeAlD
Procainamide—Nausea—Azathioprine—Crohn's disease	0.000134	0.00376	CcSEcCtD
Procainamide—SCN10A—lymph node—Crohn's disease	0.000132	0.0219	CbGeAlD
Procainamide—Vomiting—Mesalazine—Crohn's disease	0.00013	0.00367	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—Crohn's disease	0.000123	0.00347	CcSEcCtD
Procainamide—SLC22A5—digestive system—Crohn's disease	0.000122	0.0203	CbGeAlD
Procainamide—Nausea—Mesalazine—Crohn's disease	0.000122	0.00343	CcSEcCtD
Procainamide—Angioedema—Prednisone—Crohn's disease	0.000121	0.00342	CcSEcCtD
Procainamide—SCN3A—lymph node—Crohn's disease	0.00012	0.02	CbGeAlD
Procainamide—Malaise—Prednisone—Crohn's disease	0.00012	0.00337	CcSEcCtD
Procainamide—BCHE—digestive system—Crohn's disease	0.000119	0.0197	CbGeAlD
Procainamide—Convulsion—Prednisone—Crohn's disease	0.000115	0.00324	CcSEcCtD
Procainamide—Arthralgia—Prednisone—Crohn's disease	0.000113	0.00318	CcSEcCtD
Procainamide—Myalgia—Prednisone—Crohn's disease	0.000113	0.00318	CcSEcCtD
Procainamide—Discomfort—Prednisone—Crohn's disease	0.000112	0.00314	CcSEcCtD
Procainamide—Probenecid—ALB—Crohn's disease	0.000108	0.0279	CrCbGaD
Procainamide—Shock—Prednisone—Crohn's disease	0.000107	0.003	CcSEcCtD
Procainamide—SLC22A4—lymph node—Crohn's disease	0.000105	0.0175	CbGeAlD
Procainamide—Anorexia—Prednisone—Crohn's disease	0.000103	0.00291	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—Crohn's disease	9.88e-05	0.00278	CcSEcCtD
Procainamide—SLC22A3—lymph node—Crohn's disease	9.58e-05	0.0159	CbGeAlD
Procainamide—Decreased appetite—Prednisone—Crohn's disease	9.42e-05	0.00265	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—Crohn's disease	8.93e-05	0.00251	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—Crohn's disease	8.86e-05	0.00249	CcSEcCtD
Procainamide—Urticaria—Prednisone—Crohn's disease	8.61e-05	0.00242	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—Crohn's disease	8.57e-05	0.00241	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—Crohn's disease	8.57e-05	0.00241	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—Crohn's disease	7.99e-05	0.00225	CcSEcCtD
Procainamide—CYP2D6—digestive system—Crohn's disease	7.87e-05	0.0131	CbGeAlD
Procainamide—Asthenia—Prednisone—Crohn's disease	7.78e-05	0.00219	CcSEcCtD
Procainamide—Pruritus—Prednisone—Crohn's disease	7.67e-05	0.00216	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—Crohn's disease	7.42e-05	0.00209	CcSEcCtD
Procainamide—Dizziness—Prednisone—Crohn's disease	7.17e-05	0.00202	CcSEcCtD
Procainamide—SLC22A5—lymph node—Crohn's disease	6.96e-05	0.0116	CbGeAlD
Procainamide—Vomiting—Prednisone—Crohn's disease	6.89e-05	0.00194	CcSEcCtD
Procainamide—BCHE—lymph node—Crohn's disease	6.78e-05	0.0113	CbGeAlD
Procainamide—DNMT1—Gene Expression—DNMT3A—Crohn's disease	6.55e-05	0.00145	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—TYK2—Crohn's disease	6.54e-05	0.00145	CbGpPWpGaD
Procainamide—Nausea—Prednisone—Crohn's disease	6.44e-05	0.00181	CcSEcCtD
Procainamide—CHRM2—GPCR ligand binding—MLN—Crohn's disease	6.39e-05	0.00141	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—SMAD3—Crohn's disease	6.38e-05	0.00141	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	6.31e-05	0.0014	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	6.31e-05	0.0014	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	6.25e-05	0.00138	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.24e-05	0.00138	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—JAK2—Crohn's disease	6.24e-05	0.00138	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.95e-05	0.00132	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.94e-05	0.00131	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—SMAD3—Crohn's disease	5.84e-05	0.00129	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—TYK2—Crohn's disease	5.83e-05	0.00129	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.83e-05	0.00129	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	5.81e-05	0.00129	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—JAK2—Crohn's disease	5.56e-05	0.00123	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.53e-05	0.00122	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	5.4e-05	0.0012	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—TYK2—Crohn's disease	5.33e-05	0.00118	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.31e-05	0.00117	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.15e-05	0.00114	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—JAK2—Crohn's disease	5.09e-05	0.00113	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.07e-05	0.00112	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.05e-05	0.00112	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CCR6—Crohn's disease	4.84e-05	0.00107	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—SMAD3—Crohn's disease	4.72e-05	0.00104	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TYK2—Crohn's disease	4.67e-05	0.00103	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.64e-05	0.00103	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	4.57e-05	0.00101	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—SMAD3—Crohn's disease	4.51e-05	0.000999	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.51e-05	0.000998	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.51e-05	0.000998	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	4.49e-05	0.000994	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.48e-05	0.000991	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.46e-05	0.000987	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—JAK2—Crohn's disease	4.46e-05	0.000986	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCR9—Crohn's disease	4.43e-05	0.000979	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—HSPA1B—Crohn's disease	4.42e-05	0.000979	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.34e-05	0.000961	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—SMAD3—Crohn's disease	4.34e-05	0.00096	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—SMAD3—Crohn's disease	4.34e-05	0.00096	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—TYK2—Crohn's disease	4.31e-05	0.000955	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.21e-05	0.000931	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.2e-05	0.00093	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.2e-05	0.00093	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	4.2e-05	0.000929	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—SMAD3—Crohn's disease	4.18e-05	0.000925	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—SMAD3—Crohn's disease	4.18e-05	0.000925	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TYK2—Crohn's disease	4.16e-05	0.000921	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.14e-05	0.000915	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—TYK2—Crohn's disease	4.13e-05	0.000913	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—JAK2—Crohn's disease	4.12e-05	0.000911	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	4.12e-05	0.000911	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	4.03e-05	0.000891	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—JAK2—Crohn's disease	3.97e-05	0.000879	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—TYK2—Crohn's disease	3.96e-05	0.000877	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—TYK2—Crohn's disease	3.96e-05	0.000877	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	3.96e-05	0.000877	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	3.96e-05	0.000876	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	3.96e-05	0.000876	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—JAK2—Crohn's disease	3.94e-05	0.000871	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—IL6—Crohn's disease	3.9e-05	0.000863	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—UBE2D1—Crohn's disease	3.88e-05	0.000858	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.87e-05	0.000857	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	3.85e-05	0.000852	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—TYK2—Crohn's disease	3.82e-05	0.000846	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—TYK2—Crohn's disease	3.82e-05	0.000846	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TYK2—Crohn's disease	3.81e-05	0.000842	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—JAK2—Crohn's disease	3.78e-05	0.000837	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—JAK2—Crohn's disease	3.78e-05	0.000837	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—JAK2—Crohn's disease	3.65e-05	0.000807	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—JAK2—Crohn's disease	3.65e-05	0.000807	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—JAK2—Crohn's disease	3.63e-05	0.000804	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	3.61e-05	0.000799	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	3.46e-05	0.000765	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	3.39e-05	0.00075	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTMR3—Crohn's disease	3.37e-05	0.000745	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MLN—Crohn's disease	3.28e-05	0.000725	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—STAT3—Crohn's disease	3.27e-05	0.000724	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—IL6—Crohn's disease	3.2e-05	0.000708	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.18e-05	0.000703	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.17e-05	0.000702	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.16e-05	0.0007	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PLA2G4F—Crohn's disease	3.12e-05	0.00069	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TYK2—Crohn's disease	3.08e-05	0.000681	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.96e-05	0.000655	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TYK2—Crohn's disease	2.94e-05	0.000652	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—SMAD3—Crohn's disease	2.94e-05	0.000651	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—JAK2—Crohn's disease	2.94e-05	0.00065	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	2.93e-05	0.000649	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.92e-05	0.000647	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—STAT3—Crohn's disease	2.91e-05	0.000645	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—IL6—Crohn's disease	2.85e-05	0.000631	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—Crohn's disease	2.83e-05	0.000626	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TYK2—Crohn's disease	2.83e-05	0.000626	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TYK2—Crohn's disease	2.83e-05	0.000626	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—JAK2—Crohn's disease	2.81e-05	0.000622	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.81e-05	0.000621	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.8e-05	0.000619	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PLA2G4F—Crohn's disease	2.78e-05	0.000615	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—SMAD3—Crohn's disease	2.77e-05	0.000614	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TYK2—Crohn's disease	2.73e-05	0.000604	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TYK2—Crohn's disease	2.73e-05	0.000604	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—JAK2—Crohn's disease	2.7e-05	0.000597	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—JAK2—Crohn's disease	2.7e-05	0.000597	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—TYK2—Crohn's disease	2.69e-05	0.000595	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—STAT3—Crohn's disease	2.67e-05	0.00059	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTMR3—Crohn's disease	2.65e-05	0.000586	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—FADS1—Crohn's disease	2.62e-05	0.00058	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.62e-05	0.000579	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—IL6—Crohn's disease	2.61e-05	0.000577	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—JAK2—Crohn's disease	2.6e-05	0.000576	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—JAK2—Crohn's disease	2.6e-05	0.000576	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	2.58e-05	0.000571	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—JAK2—Crohn's disease	2.56e-05	0.000567	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—Crohn's disease	2.52e-05	0.000558	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	2.5e-05	0.000554	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	2.48e-05	0.00055	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GPX4—Crohn's disease	2.46e-05	0.000544	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GCKR—Crohn's disease	2.37e-05	0.000525	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTMR3—Crohn's disease	2.36e-05	0.000523	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.36e-05	0.000522	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	2.33e-05	0.000515	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	2.31e-05	0.000512	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—Crohn's disease	2.31e-05	0.000511	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—IL6—Crohn's disease	2.28e-05	0.000505	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	2.27e-05	0.000503	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.17e-05	0.000479	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—STAT3—Crohn's disease	2.16e-05	0.000477	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ALB—Crohn's disease	2.14e-05	0.000473	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	2.11e-05	0.000467	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTMR3—Crohn's disease	2.11e-05	0.000467	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—IL6—Crohn's disease	2.11e-05	0.000467	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.08e-05	0.00046	CbGpPWpGaD
Procainamide—ACHE—Metabolism—FADS1—Crohn's disease	2.06e-05	0.000457	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—STAT3—Crohn's disease	2.06e-05	0.000456	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	2.04e-05	0.000452	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—IL6—Crohn's disease	2.04e-05	0.00045	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—IL6—Crohn's disease	2.02e-05	0.000447	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.99e-05	0.00044	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—STAT3—Crohn's disease	1.98e-05	0.000438	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—STAT3—Crohn's disease	1.98e-05	0.000438	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTMR3—Crohn's disease	1.97e-05	0.000436	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—Crohn's disease	1.94e-05	0.000429	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—Crohn's disease	1.94e-05	0.000429	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MLN—Crohn's disease	1.94e-05	0.000428	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GPX4—Crohn's disease	1.93e-05	0.000428	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TYK2—Crohn's disease	1.92e-05	0.000424	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—STAT3—Crohn's disease	1.91e-05	0.000423	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—STAT3—Crohn's disease	1.91e-05	0.000423	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.89e-05	0.000418	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—Crohn's disease	1.87e-05	0.000414	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—Crohn's disease	1.87e-05	0.000414	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GCKR—Crohn's disease	1.87e-05	0.000413	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—Crohn's disease	1.87e-05	0.000413	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—Crohn's disease	1.86e-05	0.000412	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.85e-05	0.00041	CbGpPWpGaD
Procainamide—BCHE—Metabolism—FADS1—Crohn's disease	1.84e-05	0.000408	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—JAK2—Crohn's disease	1.83e-05	0.000405	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—Crohn's disease	1.78e-05	0.000395	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	1.77e-05	0.000392	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX4—Crohn's disease	1.72e-05	0.000382	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—Crohn's disease	1.71e-05	0.000379	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—Crohn's disease	1.71e-05	0.000379	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GCKR—Crohn's disease	1.67e-05	0.000369	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	1.66e-05	0.000367	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—Crohn's disease	1.65e-05	0.000366	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—Crohn's disease	1.65e-05	0.000366	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—FADS1—Crohn's disease	1.65e-05	0.000364	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	1.61e-05	0.000357	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	1.61e-05	0.000356	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	1.56e-05	0.000345	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	1.55e-05	0.000342	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX4—Crohn's disease	1.54e-05	0.000341	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—FADS1—Crohn's disease	1.53e-05	0.000339	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.51e-05	0.000334	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—Crohn's disease	1.51e-05	0.000333	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	1.5e-05	0.000333	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GCKR—Crohn's disease	1.49e-05	0.000329	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	1.47e-05	0.000325	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	1.46e-05	0.000323	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—Crohn's disease	1.44e-05	0.000319	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX4—Crohn's disease	1.44e-05	0.000318	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GCKR—Crohn's disease	1.39e-05	0.000307	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—Crohn's disease	1.38e-05	0.000306	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—Crohn's disease	1.38e-05	0.000306	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—STAT3—Crohn's disease	1.34e-05	0.000297	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR9—Crohn's disease	1.34e-05	0.000297	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.33e-05	0.000295	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—Crohn's disease	1.33e-05	0.000295	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—Crohn's disease	1.33e-05	0.000295	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	1.32e-05	0.000293	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—Crohn's disease	1.31e-05	0.000291	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.28e-05	0.000283	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GPR65—Crohn's disease	1.25e-05	0.000276	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	1.24e-05	0.000275	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.24e-05	0.000275	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.22e-05	0.000269	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	1.2e-05	0.000266	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.19e-05	0.000263	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.17e-05	0.000258	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—Crohn's disease	1.16e-05	0.000257	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL3—Crohn's disease	1.13e-05	0.00025	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	1.09e-05	0.000241	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.09e-05	0.000241	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.04e-05	0.00023	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.01e-05	0.000224	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CXCL8—Crohn's disease	9.78e-06	0.000216	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	9.45e-06	0.000209	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.42e-06	0.000209	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—Crohn's disease	9.38e-06	0.000208	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR6—Crohn's disease	8.89e-06	0.000197	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	8.73e-06	0.000193	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	8.7e-06	0.000193	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FADS1—Crohn's disease	8.47e-06	0.000187	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RBX1—Crohn's disease	8.04e-06	0.000178	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX4—Crohn's disease	7.93e-06	0.000175	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	7.9e-06	0.000175	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	7.83e-06	0.000173	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCKR—Crohn's disease	7.66e-06	0.000169	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—Crohn's disease	7.55e-06	0.000167	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	7.05e-06	0.000156	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	6.84e-06	0.000151	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL3—Crohn's disease	6.67e-06	0.000147	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—Crohn's disease	6.61e-06	0.000146	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	6.45e-06	0.000143	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—Crohn's disease	5.94e-06	0.000132	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	5.85e-06	0.000129	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	5.84e-06	0.000129	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	5.57e-06	0.000123	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	5.34e-06	0.000118	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	5.31e-06	0.000118	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—Crohn's disease	5.3e-06	0.000117	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—Crohn's disease	5.2e-06	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	5.04e-06	0.000112	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	4.85e-06	0.000107	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—Crohn's disease	4.74e-06	0.000105	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	4.67e-06	0.000103	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—Crohn's disease	4.64e-06	0.000103	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—Crohn's disease	4.41e-06	9.77e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—Crohn's disease	4.14e-06	9.17e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—Crohn's disease	3.86e-06	8.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TYK2—Crohn's disease	3.29e-06	7.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JAK2—Crohn's disease	3.14e-06	6.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	2.86e-06	6.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—Crohn's disease	2.72e-06	6.03e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—Crohn's disease	2.44e-06	5.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—Crohn's disease	2.3e-06	5.1e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.13e-06	4.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—Crohn's disease	1.61e-06	3.56e-05	CbGpPWpGaD
